Recce Pharmaceuticals secures phase II trial safety approval for breakthrough R327G treatment

Recce Pharmaceuticals Limited recently announced significant progress in its phase II clinical trial for RECCE 327 Topical Gel (R327G), an innovative treatment for acute bacterial ... Read More